Skip to main content

Lincoln Educational Services’ Fourth Quarter and Full Year 2025 Results Exceed Financial Guidance; Continued Strong Growth Forecasted for 2026

Conference Call Today, at 10:00 a.m. Eastern Time Investor Day Scheduled for March 19, 2026, at the new Nashville, TN campus PARSIPPANY, N.J., Feb. 23, 2026 (GLOBE NEWSWIRE) — Lincoln Educational Services Corporation (Nasdaq: LINC) today announced financial and operating results for the fourth quarter and fiscal year ended December 31, 2025, as well as recent business developments. Fourth Quarter 2025 Financial and Operational HighlightsRevenue of $142.9 million, increased $23.5 million, or 19.7%; 21.4% excluding the Transitional segment Net income increased to $12.7 million, or $0.40 per share, compared to $6.8 million, or $0.22 per share last year Adjusted EBITDA of $29.1 million, increased by $9.9 million, or 51.2% Net cash flow from operations of $43.5 million, compared to $30.3 million last year Student starts grew by 15.7%...

Continue reading

Axsome Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Total 4Q and full year 2025 net product revenue of $196.0 million and $638.5 million, respectively,representing 65% and 66% year-over-year growth AUVELITY® 4Q and full year 2025 net product sales of $155.1 million and $507.1 million, respectively,representing 68% and 74% year-over-year growth SUNOSI® 4Q and full year 2025 net product revenue of $36.7 million and $124.8 million, respectively,representing 40% and 32% year-over-year growth SYMBRAVO® 4Q and full year 2025 net product sales of $4.1 million and $6.6 million, respectively sNDA for AXS-05 for the treatment of Alzheimer’s disease agitation granted Priority Review with PDUFAtarget action date of April 30, 2026 Acquired AXS-17, a novel oral GABAA α2,3 receptor positive allosteric modulator Company to host conference call today at 8:00 AM Eastern NEW...

Continue reading

Exosens exceeds 2025 guidance, driven by strong Defense momentum in night vision and digital imaging; New mid-term outlook: Accelerating our profitable growth path

Exosens exceeds 2025 guidance, driven by strong Defense momentum in night vision and digital imaging New mid-term outlook: Accelerating our profitable growth path HIGHLIGHTSSustained above-guidance revenue growth of +22.1% to €468.2m in 2025, driven by strong momentum in Defense & Surveillance (accounting for 75% of 2025 revenue)Amplification revenue up +18.4%, fueled by accelerating global demand for image intensifier tubes for night vision applications; capacity expansion plan underway in Europe and the United States, already supporting an increase of 40% by 2027 D&I revenue up +28.0% in 2025, delivering solid LFL1 performance (+5.4%), which strengthened throughout the year and culminated in a particularly strong Q4 (LFL +15.9%), driven by increasing demand for imaging technologies in platform- and drone-based Defense &...

Continue reading

AirBoss to Release 4th Quarter and FY 2025 Earnings on March 4, 2026

NEWMARKET, Ontario, Feb. 20, 2026 (GLOBE NEWSWIRE) — AirBoss of America Corp. (TSX: BOS) (OTCQX:ABSSF) (the “Company” or “AirBoss”) today announced that it will release its fourth quarter and unaudited full year 2025 results after markets close on March 4, 2026. The release will be followed by a conference call to discuss the results on Thursday, March 5, 2026, at 9:00 am ET. The Company will file its audited annual consolidated financial statements and related management’s discussion and analysis for the year ended December 31, 2025 following the conclusion of the audit and in accordance with applicable securities laws. FOURTH QUARTER AND ANNUAL 2025 FINANCIAL RESULTS CONFERENCE CALL DETAILS:DATE: Thursday, March 5, 2026TIME: 9:00 am ETDIAL-IN NUMBER: 1-800-715-9871 or 1-647-932-3411 – ask to join the AirBoss call or...

Continue reading

Constellation Software Inc. Announces Change to the Date of the Conference Call to Discuss Fourth Quarter Results

TORONTO, Feb. 20, 2026 (GLOBE NEWSWIRE) — Constellation Software Inc. (TSX:CSU) announced on February 17, 2026 that it would be holding its fourth quarter conference call on March 10, 2026 at 8:00 am. Constellation has changed the date of the conference call to March 9, 2026 at 8:30 am. The Company’s quarterly results will be disseminated via press release, and made available on the Company’s website (www.csisoftware.com) and SEDAR+ (www.sedarplus.ca), at 7:00 am EST on Monday, March 9, 2026. Mark Miller, President, Jamal Baksh, Chief Financial Officer, and Bernard Anzarouth, Chief Investment Officer will be available during the March 9, 2026 conference call to answer questions regarding the Company’s results. To access the call, please dial 1-877-879-1183 (North America toll free) or 1-412-902-6703 (International) and using conference...

Continue reading

iPower Reports Fiscal Q2 2026 Results and Completes Strategic Operating Reset

RANCHO CUCAMONGA, Calif., Feb. 20, 2026 (GLOBE NEWSWIRE) — iPower Inc. (Nasdaq: IPW) (“iPower” or the “Company”) today reported financial results for the fiscal second quarter ended December 31, 2025. Revenue was $7.1 million, reflecting the Company’s deliberate supply chain restructuring and transition to predominantly U.S.-based sourcing during the quarter, while gross profit was $3.1 million and gross margin remained strong at 44.0%. Total operating expenses declined 28% year-over-year to $5.6 million compared to the quarter ended December 31, 2024. Net loss attributable to iPower was $1.2 million, or $(1.08) per share. The Company reported $2.0 million of cash and cash equivalents, $2.2 million of restricted cash, and approximately $2.2 million of digital assets. During December 2025, the Company implemented a Digital Asset...

Continue reading

U.S. Global Investors Reports 12% Sequential Growth in Assets Under Management in Q2 of Fiscal 2026

SAN ANTONIO, Feb. 20, 2026 (GLOBE NEWSWIRE) — U.S. Global Investors, Inc. (NASDAQ: GROW) (the “Company”), a registered investment advisory firm1 with longstanding experience in global markets and specialized sectors, today reported financial results for the second quarter of fiscal 2026 ended December 31, 2025. Total assets under management (AUM) were approximately $1.5 billion at quarter-end, representing a 12% increase from the prior quarter and 5% higher than AUM at the end of the year-ago quarter. This rose to $1.7 billion in total AUM as of Thursday, February 19. Operating revenue increased by $259,000, or 11.5%, compared to the prior quarter, and by $279,000 compared to the quarter ended December 31, 2024. Additionally, the Company’s expenses decreased by $172,000 in the current quarter compared to the same quarter last year....

Continue reading

Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates

2025 Total Revenue of $634M, up 17% Year-over-Year at CER Cash Position of $294M, a $44M Increase in 2025 Proposed Acquisition by BioMarin Expected to Close in Q2 2026, Subject to Closing Conditions PRINCETON, N.J., Feb. 20, 2026 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD), a leading, global biotechnology company with a clear and compelling mission to develop and deliver transformative medicines for people living with rare diseases, today announced financial results for the full year ended December 31, 2025. Full-Year 2025 Financial Highlights:Total revenues for the full year 2025 were $634.2 million, reflecting strong operational growth measured at constant exchange rates (CER)1 of 17% and a currency tailwind of ~$14 million. Fourth quarter total revenues were $185.2 million up 24%, or 20% at CER1.(in thousands) Three...

Continue reading

Federal Home Loan Bank of New York Announces Full-Year and Fourth Quarter 2025 Operating Highlights

NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) — The Federal Home Loan Bank of New York (“FHLBNY”) today released its unaudited financial highlights for the quarter and year ended December 31, 2025.  “As recent studies have found, access to Federal Home Loan Bank funding leads to increased local lending activity and broad financial stability,” said Randolph C. Snook, president and CEO of the FHLBNY. “Throughout 2025, reliable access to FHLBNY liquidity has supported our members as they make the loans that create new housing supply, support businesses small and large, and help households achieve the dream of homeownership. The impact of the daily availability of our funding was seen across 2025, as reflected in our results for the year.” Highlights from 2025 include:The FHLBNY’s net income for 2025 was $599.8 million, a decrease of...

Continue reading

Unaudited financial report for the fourth quarter and 12 months of 2025

The main business activity of Trigon Property Development AS is real estate development. As at 31.12.2025, AS Trigon Property Development owned one development project with an area of 13.2 hectares in the City of Pärnu, Estonia. A commercial, industrial and logistics park is planned on this area. The Company’s objective is to find companies willing to bring their business activities (industry, logistics) to the development project area of AS Trigon Property Development in Pärnu, which would add value to the land plots owned by the Company. As the main purpose of the company is to sell existing land plots, investment property was recognized as inventories. In the third quarter of 2024, a 0.09-hectare transportation purpose land was sold for 31,920 euros (excluding VAT). In the fourth quarter of 2024, a 0.70-hectare property was sold for...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.